Pacira Pharmaceuticals, Inc. is an acute care specialty pharmaceutical company, founded in March, 2007 through the acquisition of the former SkyePharma PLC injectable business, with a world class management team assembled to address the needs of the acute care market.
- Its most advanced product, EXPAREL™ (DepoBupivacaine), is in late Phase III clinical development.
- EXPAREL is a bupivacaine-based product intended to deliver postoperative pain relief by infiltration.
- EXPAREL benefits from the proprietary DepoFoam® Technology owned by Pacira.
- Strategic partners market two DepoFoam-based products -- DepoDur® and Depocyt(e)® -- in several global territories.
- Pacira owns two cGMP production facilities that produce the two approved products, EXPAREL clinical development and all pipeline materials.
- The DepoFoam technology is the basis of multiple development projects to potentially expand the company's pipeline.